No Data
Capricor Wins Key EU Designations for the Lead Asset
Capricor Therapeutics Granted Orphan Drug And ATMP Status For Deramiocel By EMA
Express News | Capricor Therapeutics Inc - Expects to Complete Bla Submission by End of 2024
Express News | Capricor Therapeutics Granted Orphan Drug and Atmp Status for Deramiocel by European Medicines Agency
Capricor Therapeutics Analyst Ratings
Capricor Therapeutics Initiated With a Buy at JonesResearch